Cover Image
Market Research Report

Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Published by GlobalData Product code 851180
Published Content info 627 Pages
Delivery time: 1-2 business days
Price
Back to Top
Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019
Published: May 8, 2019 Content info: 627 Pages
Description

GlobalData's Medical Devices sector report, "Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Injectable Drug Delivery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Injectable Drug Delivery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Injectable Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Injectable Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Injectable Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.
Table of Contents
Product Code: GDME0771EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Injectable Drug Delivery Devices Overview

3 Products under Development

  • 3.1 Injectable Drug Delivery Devices - Pipeline Products by Stage of Development
  • 3.2 Injectable Drug Delivery Devices - Pipeline Products by Segment
  • 3.3 Injectable Drug Delivery Devices - Pipeline Products by Territory
  • 3.4 Injectable Drug Delivery Devices - Pipeline Products by Regulatory Path
  • 3.5 Injectable Drug Delivery Devices - Pipeline Products by Estimated Approval Date
  • 3.6 Injectable Drug Delivery Devices - Ongoing Clinical Trials

4 Injectable Drug Delivery Devices - Pipeline Products under Development by Companies

  • 4.1 Injectable Drug Delivery Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Injectable Drug Delivery Devices - Pipeline Products by Stage of Development

5 Injectable Drug Delivery Devices Companies and Product Overview

  • 5.1 AdrenaCard, Inc. Company Overview
  • 5.2 Allergan Plc Company Overview
  • 5.3 Alsensa ApS Company Overview
  • 5.4 Antares Pharma Inc Company Overview
  • 5.5 Aquavit Pharmaceuticals Inc Company Overview
  • 5.6 Artemes Technologies, Inc. Company Overview
  • 5.7 Ascendis Pharma A/S Company Overview
  • 5.8 Ascil Proyectos SL Company Overview
  • 5.9 ASIS Corp Company Overview
  • 5.10 AzureBio SL Company Overview
  • 5.11 BCWorld Pharm Co Ltd Company Overview
  • 5.12 Becton Dickinson and Co Company Overview
  • 5.13 Bespak Europe Ltd Company Overview
  • 5.14 BioCorRx Inc Company Overview
  • 5.15 BioMarin Pharmaceutical Inc Company Overview
  • 5.16 BioRestorative Therapies Inc Company Overview
  • 5.17 Bioxis Pharmaceuticals Company Overview
  • 5.18 Brigham and Women's Hospital Company Overview
  • 5.19 Burke Pharmaceuticals LLC Company Overview
  • 5.20 Callisyn Biomedical Inc Company Overview
  • 5.21 Cambridge Consultants Ltd Company Overview
  • 5.22 Camurus AB Company Overview
  • 5.23 Case Western Reserve University Company Overview
  • 5.24 Catalent Inc Company Overview
  • 5.25 Cincinnati Children's Hospital Medical Center Company Overview
  • 5.26 Clearside BioMedical Inc Company Overview
  • 5.27 DALI Medical Devices Ltd. Company Overview
  • 5.28 DelSite, Inc. (Inactive) Company Overview
  • 5.29 Drexel University Company Overview
  • 5.30 Elcam Medical Company Overview
  • 5.31 EmboMedics Inc Company Overview
  • 5.32 Emergent BioSolutions Inc Company Overview
  • 5.33 EP Global Communications Inc (Inactive) Company Overview
  • 5.34 EP Technologies LLC Company Overview
  • 5.35 Eveon SAS Company Overview
  • 5.36 EyePoint Pharmaceuticals Inc Company Overview
  • 5.37 FHC Inc Company Overview
  • 5.38 GeneSYS-ID Inc Company Overview
  • 5.39 Ghent University Company Overview
  • 5.40 Globe Medical Tech Inc (Inactive) Company Overview
  • 5.41 Inovio Pharmaceuticals Inc Company Overview
  • 5.42 InVivo Therapeutics Corp Company Overview
  • 5.43 Ipsen SA Company Overview
  • 5.44 JCR Pharmaceuticals Co Ltd Company Overview
  • 5.45 Lohmann Therapie-Systeme AG Company Overview
  • 5.46 LyoGo Company Overview
  • 5.47 Mallinckrodt Plc Company Overview
  • 5.48 Mertiva AB Company Overview
  • 5.49 Midas Pharma GmbH Company Overview
  • 5.50 Milestone Scientific Inc Company Overview
  • 5.51 NanoPass Technologies Ltd Company Overview
  • 5.52 Novosanis NV Company Overview
  • 5.53 Osteo Pharma BV Company Overview
  • 5.54 Oval Medical Technologies Ltd Company Overview
  • 5.55 Particle Therapeutics Ltd Company Overview
  • 5.56 Pfizer Inc Company Overview
  • 5.57 Portal Instruments Inc Company Overview
  • 5.58 Queen Elizabeth Hospital Company Overview
  • 5.59 QuiO Technologies LLC Company Overview
  • 5.60 RepliCel Life Sciences Inc Company Overview
  • 5.61 Rescitech Vision Pvt Ltd Company Overview
  • 5.62 RetinaPharma Technologies Inc Company Overview
  • 5.63 Revance Therapeutics Inc Company Overview
  • 5.64 Roche Diagnostics International Ltd Company Overview
  • 5.65 Sapporo Medical University School of Medicine Company Overview
  • 5.66 Takeda Pharmaceutical Co Ltd Company Overview
  • 5.67 TCB medical devices Company Overview
  • 5.68 Terumo Corp Company Overview
  • 5.69 Teva Pharmaceutical Industries Ltd Company Overview
  • 5.70 TheraKine Inc (Inactive) Company Overview
  • 5.71 Twin Star Medical Inc Company Overview
  • 5.72 Unilife Corporation Company Overview
  • 5.73 University of Calgary Company Overview
  • 5.74 University of California San Diego Company Overview
  • 5.75 University of California San Francisco Company Overview
  • 5.76 University of Delaware Company Overview
  • 5.77 University of Dundee Company Overview
  • 5.78 University of Florida Company Overview
  • 5.79 University of Saskatchewan Company Overview
  • 5.80 University of Texas at Austin Company Overview
  • 5.81 Vanderbilt University Company Overview
  • 5.82 West Pharmaceutical Services Inc Company Overview
  • 5.83 Windgap Medical Inc Company Overview
  • 5.84 XERIS Pharmaceuticals Inc Company Overview
  • 5.85 Ypsomed Holding AG Company Overview

6 Injectable Drug Delivery Devices - Recent Developments

  • 6.1 Apr 24, 2019: Midatech Pharma: Audited financial results for the year ended 31 December 2018
  • 6.2 Apr 24, 2019: Alkermes appoints Industry Veteran C. Todd Nichols as Senior Vice President of Sales and Marketing
  • 6.3 Apr 23, 2019: Catalent invests $14 million at Its Eberbach, Germany Softgel facility
  • 6.4 Apr 18, 2019: Clearside Biomedical announces multiple presentations on its Suprachoroidal Space injection platform at upcoming medical meetings
  • 6.5 Apr 15, 2019: Dr. Reddy's Laboratories received the Establishment Inspection Report (BIR) from US FDA for its Manufacturing Plant -3 at Bachupally, Hyderabad
  • 6.6 Apr 11, 2019: Milestone Scientific showcases the CompuFlo Epidural Instrument at ASRA 2019
  • 6.7 Apr 11, 2019: Catalent Celebrates opening of second Shanghai facility to optimize global and local clinical supply solutions for China
  • 6.8 Apr 10, 2019: Teva signs new $2.3 billion syndicated revolving credit facility
  • 6.9 Apr 08, 2019: Generex Biotechnology appoints Mark J. Prioletti to the board of directors
  • 6.10 Apr 08, 2019: Milestone Scientific appoints fund manager and finance veteran Neal Goldman to Board of Directors

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

  • Table 1: Injectable Drug Delivery Devices - Pipeline Products by Stage of Development
  • Table 2: Injectable Drug Delivery Devices - Pipeline Products by Segment
  • Table 3: Injectable Drug Delivery Devices - Pipeline Products by Territory
  • Table 4: Injectable Drug Delivery Devices - Pipeline Products by Regulatory Path
  • Table 5: Injectable Drug Delivery Devices - Pipeline Products by Estimated Approval Date
  • Table 6: Injectable Drug Delivery Devices - Ongoing Clinical Trials
  • Table 7: Injectable Drug Delivery Devices Companies - Pipeline Products by Stage of Development
  • Table 8: Injectable Drug Delivery Devices - Pipeline Products by Stage of Development
  • Table 9: AdrenaCard, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Adrenacard Auto-Injector - Product Status
  • Table 11: Adrenacard Auto-Injector - Product Description
  • Table 12: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: NOVADUR Intravitreal Implant - Product Status
  • Table 14: NOVADUR Intravitreal Implant - Product Description
  • Table 15: Alsensa ApS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: SQJCT - Product Status
  • Table 17: SQJCT - Product Description
  • Table 18: Antares Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Methotrexate Auto Injector - Ectopic Pregnancy - Product Status
  • Table 20: Methotrexate Auto Injector - Ectopic Pregnancy - Product Description
  • Table 21: Vibex QS M - Product Status
  • Table 22: Vibex QS M - Product Description
  • Table 23: Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: PITO-001 - Product Status
  • Table 25: PITO-001 - Product Description
  • Table 26: Artemes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Artemes Magnetic Injection System - Product Status
  • Table 28: Artemes Magnetic Injection System - Product Description
  • Table 29: Ascendis Pharma A/S Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: TransCon hGH Auto-Injector - Product Status
  • Table 31: TransCon hGH Auto-Injector - Product Description
  • Table 32: Ascendis Pharma A/S - Ongoing Clinical Trials Overview
  • Table 33: TransCon hGH Auto-Injector - A Multicenter, Phase III, Long-term, Open-label Trial Investigating Safety and Efficacy of TransCon hGH Administered Once-weekly in Children with Growth Hormone Deficiency (GHD) Who Have Completed a Prior TransCon hGH Clinical Trial: enliGHten
  • Table 34: TransCon hGH Auto-Injector - fliGHT: A Multicenter, Phase 3, Open-label, 26-week Trial Investigating the Safety, Tolerability and Efficacy of Transcon Hgh Administered Once Weekly in Children With GHD
  • Table 35: Ascil Proyectos SL Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: ASTECH - Product Status
  • Table 37: ASTECH - Product Description
  • Table 38: Combo Connector - Dual Chamber Device - Product Status
  • Table 39: Combo Connector - Dual Chamber Device - Product Description
  • Table 40: Combo Connector - Microdosing Device - Product Status
  • Table 41: Combo Connector - Microdosing Device - Product Description
  • Table 42: Combo Connector - Prefilled Device - Product Status
  • Table 43: Combo Connector - Prefilled Device - Product Description
  • Table 44: Combo-Connector Device - Product Status
  • Table 45: Combo-Connector Device - Product Description
  • Table 46: ASIS Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: Automatic Subdermal Injection System - Product Status
  • Table 48: Automatic Subdermal Injection System - Product Description
  • Table 49: ASIS Corp - Ongoing Clinical Trials Overview
  • Table 50: Automatic Subdermal Injection System - ASIS for Botox in Chronic Migraine
  • Table 51: Automatic Subdermal Injection System - ASIS for Botox in Upper Limb Spasticity
  • Table 52: Automatic Subdermal Injection System - ASIS for Enbrel in Plaque Psoriasis
  • Table 53: AzureBio SL Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Injectable Needle - Product Status
  • Table 55: Injectable Needle - Product Description
  • Table 56: BCWorld Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: LASTINA Microsphere - Product Status
  • Table 58: LASTINA Microsphere - Product Description
  • Table 59: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: BD Intevia Disposable Autoinjector - Product Status
  • Table 61: BD Intevia Disposable Autoinjector - Product Description
  • Table 62: BD Libertas Wearable Injector - Product Status
  • Table 63: BD Libertas Wearable Injector - Product Description
  • Table 64: BD Neopak XSi Glass Pre-Fillable Syringe - Product Status
  • Table 65: BD Neopak XSi Glass Pre-Fillable Syringe - Product Description

List of Figures

  • Figure 1: Injectable Drug Delivery Devices - Pipeline Products by Stage of Development
  • Figure 2: Injectable Drug Delivery Devices - Pipeline Products by Segment
  • Figure 3: Injectable Drug Delivery Devices - Pipeline Products by Territory
  • Figure 4: Injectable Drug Delivery Devices - Pipeline Products by Regulatory Path
  • Figure 5: Injectable Drug Delivery Devices - Pipeline Products by Estimated Approval Date
  • Figure 6: Injectable Drug Delivery Devices - Ongoing Clinical Trials
Back to Top